Key terms
About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest JNJ news
Yesterday 3:58pm ET Paging Dr. Nvidia (NASDAQ:NVDA): AI and Healthcare by TipRanks Mar 28 1:57pm ET J&J to pay $75M to settle $6B baby powder lawsuit, Bloomberg reports by TipRanks Mar 28 10:08am ET J&J to pay $75M to settle Mississipi talc lawsuit, Bloomberg says by TipRanks Mar 27 3:50pm ET Judge gives J&J new chance to contest evidence on talc products, Reuters says by TipRanks Mar 27 8:14am ET Piper says competitive process could materialize for ShockWave by TipRanks Mar 26 8:02pm ET Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Healthequity (HQY) and Bluebird Bio (BLUE) by TipRanks Mar 26 2:23pm ET Johnson & Johnson in talks to acquire Shockwave Medical, WSJ says by TipRanks Mar 26 2:20pm ET ShockWave jumps 8% to $311.29 after WSJ report of J&J talks by TipRanks Mar 26 2:19pm ET J&J in talks to acquire ShockWave Medical, WSJ reports by TipRanks Mar 18 9:19am ET Arcellx price target raised to $81 from $72 at Needham by TipRanks Mar 18 7:07am ET Clearside Biomedical appoints Chong as Chief Medical Officer by TipRanks Mar 18 6:50am ET Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Aveanna Healthcare Holdings (AVAH) by TipRanks Mar 15 3:17pm ET Legend Biotech notes ODAC recommends Carvykti for earlier treatment of myeloma by TipRanks Mar 15 3:03pm ET J&J says ODAC recommends Carvykti for earlier treatment of myeloma by TipRanks Mar 15 12:51pm ET FDA advisors vote in favor of expanding label of J&J’s Carvykti by TipRanks Mar 15 12:03pm ET JPMorgan biotech/pharma analysts hold an analyst/industry conference call by TipRanks Mar 14 12:15am ET Johnson & Johnson (JNJ) Receives a Buy from Cantor Fitzgerald by TipRanks Mar 13 8:04am ET Foot Locker appoints Cindy Carlisle as Chief Human Resources Officer by TipRanks Mar 08 8:57am ET Neumora Therapeutics price target raised to $31 from $24 at RBC Capital by TipRanks Mar 07 2:15pm ET Johnson & Johnson put volume heavy and directionally bearish by TipRanks Mar 06 1:22pm ET Ambrx Biopharma shareholders approve acquisition by Johnson & Johnson by TipRanks Mar 06 10:07am ET High Benzene Levels Found in Multiple Brands’ Acne Treatments by TipRanks Mar 06 9:43am ET J&J unit applies for Darzalex quadruplet therapy in Europe by TipRanks Mar 06 9:20am ET Lab says chemical linked to cancer found in acne creams, Bloomberg reports by TipRanks Mar 01 4:00pm ET Johnson & Johnson says Rybrevant-chemotherapy combo approved by FDA by TipRanks Feb 29 6:32am ET Barclays Keeps Their Hold Rating on Johnson & Johnson (JNJ) by TipRanks Feb 28 7:23am ET Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), Masimo (MASI) and Johnson & Johnson (JNJ) by TipRanks Feb 28 5:38am ET Hold Rating on Johnson & Johnson Amid Anticipated Varipulse Approval and Afib Market Dynamics by TipRanks Feb 23 7:23am ET Legend Biotech gets CHMP recommendation for expansion of Carvykti label by TipRanks Feb 21 7:25am ET BTIG medical technology analyst to hold analyst/industry conference call by TipRanks Feb 21 4:55am ET BTIG medical technology analyst to hold analyst/industry conference call by TipRanks
Today 5:19am ET 3 Reliable Dividend Growth Stocks With Yields Above 3% That You Can Buy Now and Hold for at Least a Decade by Motley Fool Yesterday 9:00am ET Why Shockwave Medical Stock Rallied as Much as 18% Higher This Week by Motley Fool Mar 28 6:15am ET 3 Dividend Stocks That Are Likely to Raise Their Payouts in April by Motley Fool Mar 22 4:25am ET Want Decades of Passive Income? 2 Stocks to Buy Now. by Motley Fool Mar 21 5:02am ET Should You Buy 3M Before April 1? by Motley Fool Mar 16 8:15am ET Meet the "Magnificent Seven" Stock That Pays More Dividends Than Any Other U.S.-Based Company by Motley Fool Mar 16 3:55am ET Johnson & Johnson Stock Is Great. Here's Why You Shouldn't Buy It. by Motley Fool Mar 13 5:21am ET 3 No-Brainer Stocks to Buy With $300 Right Now by Motley Fool Mar 12 6:53am ET 2 High-Yield Dow Jones Dividend Stocks to Buy Now and Hold Forever by Motley Fool Mar 11 5:35am ET 3 Dividend Kings of Healthcare Stocks to Buy Hand Over Fist in March by Motley Fool
No recent press releases are available for JNJ
JNJ Financials
1-year income & revenue
Key terms
Ad Feedback
JNJ Forecasts
analyst rating
- buy
- hold
- sell
We're sorry, but this
information is
temporarily unavailable.
1-year stock price forecast
JNJ Competitors
$ Market cap P/E ratio $ Price 1d change 52-week range
